-
Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
This company is turning into Frat Central!
Discussion in 'Exact Sciences' started by Anonymous, Mar 19, 2015 at 7:25 AM.